Bill Edelman, is a medical device industry executive with over 40 years experience and currently serves as Chairman of the Board for Highland Instruments, Inc., (neurostimulation), Paragonix Technologies, Inc., (organ transport systems), and Corsens (cardiac monitoring). Mr Edelman serves as a member of the Advisory Council for the Department of Biomedical Engineering at Rensselaer Polytechnic Institute (Troy, NY).
Mr. Edelman previously served as CEO for ETView, Ltd., (TASE: ETVW) (airway management) acquired by Ambu A/S(CPH:AMBU-B) September 2016, member of the Screening Committee for Medical Devices for Mass Medical Angels, Chairman of the Board for Vitathreads LLC, (aesthetics wound repair), NewVert, Ltd., (spinal implants), Flexicath, Ltd., (IV catheterization), Board Member for MindChild Medical, Inc., (non-invasive fetal monitoring), PolyTouch, Ltd., (general surgical instrumentation) (acquired by Covidien in 2011), Stimatix GI, Ltd., (ostomy products), Medivalve, Ltd., (percutaneous aortic valve placement), Cardioflow, Ltd., (embolic protection) and Leviticus Cardio, Ltd., (cardiac assist power systems). Mr. Edelman has also served a Advisor on the Heathcare Board, for Northeast Securities, Inc., and Advisor to First Light Bioscienses, Inc. (automated medical diagnostic products).